Antiseptic bathing products market to hit $28.22B by 2030

By AI, Created 10:42 AM UTC, May 20, 2026, /AGP/ – The antiseptic bathing products market is projected to grow from $21.11 billion in 2025 to $28.22 billion by 2030, driven by infection-control needs, skin health concerns and stronger patient-safety standards. North America led in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - The market is tied to hospital infection control, surgical site infection prevention and ICU hygiene, making it relevant to patient safety and clinical operations. - Demand is also rising from broader use in homecare hygiene and skin-health routines. - The growth outlook points to steady spending in products that reduce microbial risk on skin.

What happened: - The Business Research Company published a 2026 market update on antiseptic bathing products. - The market is estimated at $21.11 billion in 2025 and is forecast to reach $22.38 billion in 2026. - The report projects the market will rise to $28.22 billion by 2030. - The forecast implies a 6.0% compound annual growth rate from 2025 through 2030. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific is expected to be the fastest-growing region over the forecast period.

The details: - Antiseptic bathing products are cleansing agents designed to reduce or eliminate microorganisms on the skin. - Common active ingredients include chlorhexidine, iodine and quaternary ammonium compounds. - Growth drivers listed in the report include hospital-acquired infection concerns, surgical site infection prevention, ICU patient-care protocols, wider antiseptic adoption and stricter clinical hygiene rules. - Looking ahead, the report points to infection-prevention investment, antimicrobial-resistance awareness, expanding ICU capacity, broader acceptance of homecare hygiene products and higher patient-safety standards. - The report highlights chlorhexidine-based formulations, no-rinse antiseptic bathing products, stronger ICU hygiene protocols and skin-friendly antimicrobial solutions as key trends. - The market coverage spans Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample is available here. - The full report is available here.

Between the lines: - The forecast suggests antiseptic bathing is shifting from a narrow hospital use case to a broader hygiene and prevention category. - Skin-disease prevalence adds another demand layer beyond acute-care settings. - A June 2025 public health study published by Frontiers projected a 37.2% increase in fungal skin disease incidence globally from 2022 to 2050, along with a 38.6% rise in disability-adjusted life years and a 40.4% increase in prevalence cases. - The report uses that trend to reinforce demand for products that help reduce microbes and prevent infection.

What’s next: - The market is expected to keep growing at a 6.0% annual pace through 2030. - Product innovation is likely to center on no-rinse formats, chlorhexidine-based lines and gentler antimicrobial formulas. - Regional growth should remain strongest in Asia-Pacific as healthcare systems expand ICU capacity and infection-prevention spending.

The bottom line: - Antiseptic bathing products are moving from a hospital staple to a wider infection-prevention category with a clear growth path through 2030.